Remove Clinical Research Remove Drugs Remove Pharma Companies Remove White Paper
article thumbnail

Top 10 Drug Discovery Trends at the Top 20 Pharma

PerkinElmer

Industry leaders reveal how high throughput screening is changing in R&D What do you think are the major trends in drug discovery R&D? That is not what PerkinElmer found in a comprehensive survey of leaders at the top 20 Pharma, ranked for R&D spending. A PerkinElmer White Paper offers a detailed look at the findings.

article thumbnail

Keeping tabs on Covid-19: Starpharma creates slow release remdesivir nanoparticl…

The Pharma Data

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. acting, water-soluble version of remdesivir.

article thumbnail

Keeping tabs on Covid-19: BetterLife embraces virtual clinical trials and Novan shares positive results from in vitro antiviral technology against SARS-CoV-2

The Pharma Data

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. With many nationwide and regional lockdowns coming into force, virtual clinical trials are proving to be an effective way to monitor patients remotely.